Marinus Pharmaceuticals Inc (MRNS)
0.532
0.00 (0.00%)
USD |
NASDAQ |
Jan 08, 16:00
0.53
0.00 (0.00%)
After-Hours: 04:59
Marinus Pharmaceuticals SG&A Expense (Quarterly): 12.57M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 76.60M |
| Traws Pharma Inc | 3.48M |
| Viking Therapeutics Inc | 13.77M |
| Rocket Pharmaceuticals Inc | 27.11M |
| Axsome Therapeutics Inc | 95.56M |